Magar, S. D., & Pawar, P. Y. (2022). In silico ADMET screening & molecular docking of some 1-(5-(4-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl) ethanone derivatives to be developed as triple mutant T790M/C797S EGFR inhibitors. International Journal of Health Sciences, 6(S3), 10432–10451. https://doi.org/10.53730/ijhs.v6nS3.9448